1. Home
  2. ARVN vs WGO Comparison

ARVN vs WGO Comparison

Compare ARVN & WGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARVN
  • WGO
  • Stock Information
  • Founded
  • ARVN 2015
  • WGO 1958
  • Country
  • ARVN United States
  • WGO United States
  • Employees
  • ARVN N/A
  • WGO N/A
  • Industry
  • ARVN Biotechnology: Pharmaceutical Preparations
  • WGO Homebuilding
  • Sector
  • ARVN Health Care
  • WGO Industrials
  • Exchange
  • ARVN Nasdaq
  • WGO Nasdaq
  • Market Cap
  • ARVN 1.4B
  • WGO 1.6B
  • IPO Year
  • ARVN 2018
  • WGO N/A
  • Fundamental
  • Price
  • ARVN $18.57
  • WGO $48.45
  • Analyst Decision
  • ARVN Strong Buy
  • WGO Strong Buy
  • Analyst Count
  • ARVN 13
  • WGO 9
  • Target Price
  • ARVN $63.00
  • WGO $63.50
  • AVG Volume (30 Days)
  • ARVN 860.7K
  • WGO 992.0K
  • Earning Date
  • ARVN 02-25-2025
  • WGO 12-20-2024
  • Dividend Yield
  • ARVN N/A
  • WGO 2.68%
  • EPS Growth
  • ARVN N/A
  • WGO N/A
  • EPS
  • ARVN N/A
  • WGO N/A
  • Revenue
  • ARVN $161,100,000.00
  • WGO $2,836,100,000.00
  • Revenue This Year
  • ARVN $239.85
  • WGO $0.42
  • Revenue Next Year
  • ARVN N/A
  • WGO $9.14
  • P/E Ratio
  • ARVN N/A
  • WGO N/A
  • Revenue Growth
  • ARVN 1.07
  • WGO N/A
  • 52 Week Low
  • ARVN $17.08
  • WGO $45.44
  • 52 Week High
  • ARVN $53.08
  • WGO $74.10
  • Technical
  • Relative Strength Index (RSI)
  • ARVN 43.53
  • WGO 43.51
  • Support Level
  • ARVN $17.35
  • WGO $46.95
  • Resistance Level
  • ARVN $21.00
  • WGO $50.31
  • Average True Range (ATR)
  • ARVN 1.18
  • WGO 1.77
  • MACD
  • ARVN 0.12
  • WGO 0.40
  • Stochastic Oscillator
  • ARVN 38.01
  • WGO 55.95

About ARVN Arvinas Inc.

Arvinas Inc is a United States-based biopharmaceutical company focused on improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies that degrade disease-causing proteins.. The company's proprietary Proteolysis-Targeting Chimera (PROTAC), work by inducing the cell's own ubiquitin-proteasome system to target, degrade and remove disease-causing proteins. The group's product candidates are bavdegalutamide, ARV-471 and ARV-766.

About WGO Winnebago Industries Inc.

Winnebago Industries manufactures Class A, B, and C motor homes along with towables, customized specialty vehicles, boats, and parts. Headquartered in Eden Prairie, Minnesota, Winnebago has been producing recreational vehicles since 1958. Revenue was nearly $3 billion in fiscal 2024. Winnebago expanded into towables in 2011 with the acquisition of SunnyBrook and acquired Grand Design in November 2016. Towables made up 83% of the firm's RV unit volume, up from 31% in fiscal 2016. The company's total RV unit volume was 38,796 in fiscal 2024. Winnebago expanded into boating in 2018 with the purchase of Chris-Craft, bought premium motor home maker Newmar in November 2019, and bought Barletta pontoon boats in August 2021. It also is developing electric and autonomous technology.

Share on Social Networks: